KAHR medical
Jerusalem
About KAHR medical
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $138.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: kahrbio.com
- Phone: 97246392752
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/kahr-medical-24700 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.